Review
BibTex RIS Cite

Obezite ve Gebelik

Year 2018, Volume: 2 Issue: 3, 101 - 106, 28.12.2018

Gülhan Duman Fahri Bayram

Abstract

Doğurganlık çağındaki kadınların %50’si fazla kilolu [vücut
kitle indeksi (VKI): 24.9-29.9kg/m²] ya da obezdir (BMI>30 kg/m²), %18’i
gebeliğe başlarken obezdir. Amerika Birleşik Devletleri ve Avrupa’da %20-40
kadın gebelik sırasında önerilenden fazla kilo almaktadır, bu ise maternal ve
fetal komplikasyonların artışı ile sonuçlanmaktadır. Gebelik, doğum ve doğum
sonrasında ölen kadınların yarıdan fazlası kilolu ya da obezdir.  Obezitenin ciddi problem olduğu günümüzde gebeliğe obez başlayan veya gebelik sırasında fazla kilo alan gebelerin yönetimi hem anne hem fetüs sağlığı için önemlidir. özellikle sağlıksız bir mikroçevreye maruz kalan fetüste ileride de ciddi metabolik problemler gelişmektedir. 

Keywords

obezite gebelik

References

  • 1- Thangaratinam S, Rogozińska E, Jolly K, Glinkowski S, Duda W, Borowiack E, Khan K. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technology Assessment. 2012; 16(31):1366-5278.
  • 2- Davies GA. L, Maxwell C, McLeod L. Obesity in Pregnancy, SOGC Clinical Practice Guideline. JOGC. 2010; 209:165-73.
  • 3- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health Karger.2013; 34: 1-7.
  • 4- Hajagos-Tóth J, Ducza E, Samavati R, Vari S.G, Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croatian Medical Journal. 2017; 58(2), 96-104.
  • 5- Lashen H, Fear K, Sturdee DW, Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004; 19: 1644-1646.
  • 6- Abdollahi M, Cushman M, Rosendaal FR, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89: 493-498.
  • 7- Yogev Y, Catalano PM. Pregnancy and Obesity. Obstet Gynecol Clin N Am. 2009;36: 285-300.
  • 8- Davies GA, Maxwell C, McLeod L. SOGC Clinical Practice Guidelines: Obesity in pregnancy. Int J Gynaecol Obstet. 2010; 110:1673- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health. Karger.2013; 34 :1-7.
  • 9- Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who is at risk for prolonged and postterm pregnancy? Am J Obstet Gynecol. 2009;200: 683-5.10- American College of Obstetricans and Gynecologists Committee on Obstetric Practice. 2013; 549.
  • 11- James A. Committee on Practice Bulletins-Obstetrics. Tromboembolism in pregnancy. Obstet Gynecol. 2011;118:718.
  • 12- IOM (Institute of Medicine) and NRC (National ResearchCouncil). Weight Gain During Pregnancy:Reexamining the Guidelines. The National Academies Pres. Washington, DC; 2009.
  • 13- The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008; 89: 505-522.
  • 14- Jain A. P, Gavard J. A, Rice J. J, Catanzaro R. B, Artal R, Hopkins S. A. The Impact of Interpregnancy Weight Change on Birthweight in Obese Women. Obstetrical & Gynecological Survey. 2013; 68(6): 409-411.
  • 15- Glazer N. L, Hendrickson A. F, Schellenbaum G. D, Mueller B. A. Weight Change and the Risk of Gestational Diabetes in Obese Women. Epidemiology. 2004; 15(6): 733-737.
  • 16- American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017; 40 (Supplement 1):11-24.
  • 17- Clinical practice guidelines for healthy eating for the preventıon and treatment of metabolic and endocrine diseases in adults:cosponsored by the Amerıcan Association of clinical endocrinologists/ the American College of Endocrınology. Endocrine Practice. 2013;19 (Suppl 3).
  • 18- Harborne L, Sattar N, Norman J.E, Fleming, R. Metformin and weight loss in obese womenwith polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005; 90: 4593-8.
  • 19- Li Z, Magione M, Tu W, et al (RAND Health Division, Santa Monica, Calif; Greater Los Angeles VA Healthcare System; Dept of Veterans Affairs, Cincinnati, Ohio). Meta - analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005; 142: 532-46.
  • 20- Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and Surgical Management of Obesity in Primary Care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142: 525-31.

Year 2018, Volume: 2 Issue: 3, 101 - 106, 28.12.2018

Gülhan Duman Fahri Bayram

Abstract

References

  • 1- Thangaratinam S, Rogozińska E, Jolly K, Glinkowski S, Duda W, Borowiack E, Khan K. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technology Assessment. 2012; 16(31):1366-5278.
  • 2- Davies GA. L, Maxwell C, McLeod L. Obesity in Pregnancy, SOGC Clinical Practice Guideline. JOGC. 2010; 209:165-73.
  • 3- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health Karger.2013; 34: 1-7.
  • 4- Hajagos-Tóth J, Ducza E, Samavati R, Vari S.G, Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croatian Medical Journal. 2017; 58(2), 96-104.
  • 5- Lashen H, Fear K, Sturdee DW, Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004; 19: 1644-1646.
  • 6- Abdollahi M, Cushman M, Rosendaal FR, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89: 493-498.
  • 7- Yogev Y, Catalano PM. Pregnancy and Obesity. Obstet Gynecol Clin N Am. 2009;36: 285-300.
  • 8- Davies GA, Maxwell C, McLeod L. SOGC Clinical Practice Guidelines: Obesity in pregnancy. Int J Gynaecol Obstet. 2010; 110:1673- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health. Karger.2013; 34 :1-7.
  • 9- Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who is at risk for prolonged and postterm pregnancy? Am J Obstet Gynecol. 2009;200: 683-5.10- American College of Obstetricans and Gynecologists Committee on Obstetric Practice. 2013; 549.
  • 11- James A. Committee on Practice Bulletins-Obstetrics. Tromboembolism in pregnancy. Obstet Gynecol. 2011;118:718.
  • 12- IOM (Institute of Medicine) and NRC (National ResearchCouncil). Weight Gain During Pregnancy:Reexamining the Guidelines. The National Academies Pres. Washington, DC; 2009.
  • 13- The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008; 89: 505-522.
  • 14- Jain A. P, Gavard J. A, Rice J. J, Catanzaro R. B, Artal R, Hopkins S. A. The Impact of Interpregnancy Weight Change on Birthweight in Obese Women. Obstetrical & Gynecological Survey. 2013; 68(6): 409-411.
  • 15- Glazer N. L, Hendrickson A. F, Schellenbaum G. D, Mueller B. A. Weight Change and the Risk of Gestational Diabetes in Obese Women. Epidemiology. 2004; 15(6): 733-737.
  • 16- American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017; 40 (Supplement 1):11-24.
  • 17- Clinical practice guidelines for healthy eating for the preventıon and treatment of metabolic and endocrine diseases in adults:cosponsored by the Amerıcan Association of clinical endocrinologists/ the American College of Endocrınology. Endocrine Practice. 2013;19 (Suppl 3).
  • 18- Harborne L, Sattar N, Norman J.E, Fleming, R. Metformin and weight loss in obese womenwith polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005; 90: 4593-8.
  • 19- Li Z, Magione M, Tu W, et al (RAND Health Division, Santa Monica, Calif; Greater Los Angeles VA Healthcare System; Dept of Veterans Affairs, Cincinnati, Ohio). Meta - analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005; 142: 532-46.
  • 20- Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and Surgical Management of Obesity in Primary Care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142: 525-31.
There are 19 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Gülhan Duman

Fahri Bayram

Publication Date December 28, 2018
Acceptance Date December 28, 2018
Published in Issue Year 2018 Volume: 2 Issue: 3

Cite

APA Duman, G., & Bayram, F. (2018). Obezite ve Gebelik. Türkiye Diyabet Ve Obezite Dergisi, 2(3), 101-106.
AMA Duman G, Bayram F. Obezite ve Gebelik. Turk J Diab Obes. December 2018;2(3):101-106.
Chicago Duman, Gülhan, and Fahri Bayram. “Obezite Ve Gebelik”. Türkiye Diyabet Ve Obezite Dergisi 2, no. 3 (December 2018): 101-6.
EndNote Duman G, Bayram F (December 1, 2018) Obezite ve Gebelik. Türkiye Diyabet ve Obezite Dergisi 2 3 101–106.
IEEE G. Duman and F. Bayram, “Obezite ve Gebelik”, Turk J Diab Obes, vol. 2, no. 3, pp. 101–106, 2018.
ISNAD Duman, Gülhan - Bayram, Fahri. “Obezite Ve Gebelik”. Türkiye Diyabet ve Obezite Dergisi 2/3 (December 2018), 101-106.
JAMA Duman G, Bayram F. Obezite ve Gebelik. Turk J Diab Obes. 2018;2:101–106.
MLA Duman, Gülhan and Fahri Bayram. “Obezite Ve Gebelik”. Türkiye Diyabet Ve Obezite Dergisi, vol. 2, no. 3, 2018, pp. 101-6.
Vancouver Duman G, Bayram F. Obezite ve Gebelik. Turk J Diab Obes. 2018;2(3):101-6.
 Download Cover Image

Turkish Journal of Diabetes and Obesity (Turk J Diab Obes) is a scientific publication of Zonguldak Bulent Ecevit University Obesity and Diabetes Research and Application Center.

This is a refereed journal, which is published in printed and electronic forms. It aims at achieving free knowledge to the related national and international organizations and individuals.

This journal is published annually three times (in April, August and December).

The publication language of the journal is Turkish and English.